Outset Medical, Inc., a leader in innovative medical technology, has announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its new product, TabloCart with prefiltration. This accessory is designed to enhance the functionality of the Tablo Hemodialysis System, already known for its revolutionary approach to dialysis by reducing the procedure’s […]
Pfizer Inc. (NYSE: PFE) announced a significant breakthrough in hemophilia treatment with the U.S. Food and Drug Administration’s approval of BEQVEZ (fidanacogene elaparvovec-dzkt), a pioneering gene therapy for adults with moderate to severe hemophilia B. This one-time treatment, designed to enable patients to internally produce the blood-clotting factor IX (FIX), offers a potential life-changing alternative […]
Amgen (NASDAQ: AMGN), a global biotechnology leader, has announced its plans to submit a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for teprotumumab. This treatment, a fully human monoclonal antibody and targeted inhibitor of the insulin-like growth factor-1 receptor (IGF-1R), is aimed at adults suffering from moderate to severe Thyroid Eye Disease […]
Eli Lilly and Company (NYSE: LLY) has released positive topline results from the phase 3 SURMOUNT-OSA clinical trials, demonstrating that tirzepatide injection significantly reduces the apnea-hypopnea index (AHI) compared to placebo. Tirzepatide, already known for chronic weight management under the brand names Zepbound in the U.S. and Mounjaro globally, now shows promise in treating moderate-to-severe […]
Kiosk Operators LLC, a prominent provider of kiosk and locker solutions, has recently acquired Wellmation, a leader in pharmaceutical kiosk technology. This strategic move incorporates Wellmation’s extensive patents, software, hardware, and intellectual property. The acquisition not only solidifies Kiosk Operators LLC’s presence in the pharmaceutical industry but also sets the stage for significant advancements in […]
Biocon Limited (BSE code: 532523, NSE: BIOCON), a leader in global biopharmaceutical innovations, has announced a pivotal licensing and supply agreement with Brazil’s Biomm S.A., a specialty pharmaceutical company, to commercialize Semaglutide, a drug aimed at enhancing glycemic control in adults with type-2 diabetes. This exclusive partnership allows Biocon to handle the development, manufacturing, and […]
Happiest Minds Technologies Limited (NSE: HAPPSTMNDS), a pioneer in digital and agile technology solutions, announced the launch of its latest innovation: the hAppI chatbot. Developed by its Generative AI Business Services (GBS) unit for Happiest Health, hAppI is a Generative AI-powered chatbot designed to significantly enhance the way individuals access health and wellness information. Joseph […]
Vera Whole Health, in collaboration with Anthem Blue Cross and Blue Shield of Georgia, has officially launched four advanced primary care centers in Atlanta. These centers aim to enhance the accessibility of high-quality primary care for Anthem members who are enrolled in commercial employer-based and Health Insurance Exchange plans. This strategic partnership marks a significant […]
Primel, a pioneer in the realm of infection prevention solutions, has announced remarkable results from a recent study, confirming the superior sporicidal activity of its Active Hand Coating. Demonstrating more than 99.99% efficacy with a short contact time of just 30 seconds against Clostridium difficile (C. diff), this innovation is set to revolutionize the global […]
Bristol Myers Squibb (NYSE: BMY) has reached a pivotal milestone in the treatment of non-small cell lung cancer (NSCLC) with its announcement regarding the KRYSTAL-12 study’s success. The study focused on evaluating KRAZATI (adagrasib) as a monotherapy for patients with pretreated locally advanced or metastatic NSCLC harboring a KRASG12C mutation. KRAZATI met the primary endpoint […]